These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23085145)

  • 1. Effects of 5-fluorouracil chemotherapy on fatigue: role of MCP-1.
    Mahoney SE; Davis JM; Murphy EA; McClellan JL; Gordon B; Pena MM
    Brain Behav Immun; 2013 Jan; 27(1):155-61. PubMed ID: 23085145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary quercetin reduces chemotherapy-induced fatigue in mice.
    Mahoney SE; Davis JM; Murphy EA; McClellan JL; Pena MM
    Integr Cancer Ther; 2014 Sep; 13(5):417-24. PubMed ID: 24626097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells.
    Yasuda M; Kato S; Yamanaka N; Iimori M; Matsumoto K; Utsumi D; Kitahara Y; Amagase K; Horie S; Takeuchi K
    Br J Pharmacol; 2013 Mar; 168(6):1388-400. PubMed ID: 23072534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil recruitment is critical for 5-fluorouracil-induced diarrhea and the decrease in aquaporins in the colon.
    Sakai H; Sagara A; Matsumoto K; Jo A; Hirosaki A; Takase K; Sugiyama R; Sato K; Ikegami D; Horie S; Matoba M; Narita M
    Pharmacol Res; 2014 Sep; 87():71-9. PubMed ID: 24972040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
    Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
    BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Ingredients of Hange-shashin-to, Baicalelin and 6-Gingerol, Inhibit 5-Fluorouracil-Induced Upregulation of CXCL1 in the Colon to Attenuate Diarrhea Development.
    Sakai H; Tabata S; Kimura M; Yabe S; Isa Y; Kai Y; Sato F; Yumoto T; Miyano K; Narita M; Uezono Y
    Biol Pharm Bull; 2017; 40(12):2134-2139. PubMed ID: 29199237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice.
    Araújo CV; Lazzarotto CR; Aquino CC; Figueiredo IL; Costa TB; Alves LA; Ribeiro RA; Bertolini LR; Lima AA; Brito GA; Oriá RB
    Braz J Med Biol Res; 2015 Jun; 48(6):493-501. PubMed ID: 25945744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin Inhibits 5-Fluorouracil-induced Up-regulation of CXCL1 and CXCL2 of the Colon Associated with Attenuation of Diarrhoea Development.
    Sakai H; Kai Y; Oguchi A; Kimura M; Tabata S; Yaegashi M; Saito T; Sato K; Sato F; Yumoto T; Narita M
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):540-547. PubMed ID: 27194111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of voluntary wheel running on neuroinflammatory status: Role of monocyte chemoattractant protein-1.
    Spielman LJ; Estaki M; Ghosh S; Gibson DL; Klegeris A
    Mol Cell Neurosci; 2017 Mar; 79():93-102. PubMed ID: 28088610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion.
    Grem JL; Quinn M; Ismail AS; Takimoto CH; Lush R; Liewehr DJ; Steinberg SM; Balis FM; Chen AP; Monahan BP; Harold N; Corse W; Pang J; Murphy RF; Allegra CJ; Hamilton JM
    Cancer Chemother Pharmacol; 2001; 47(2):117-25. PubMed ID: 11269737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4.
    Soares PM; Mota JM; Souza EP; Justino PF; Franco AX; Cunha FQ; Ribeiro RA; Souza MH
    Cytokine; 2013 Jan; 61(1):46-9. PubMed ID: 23107827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
    Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
    Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice.
    Sezaki T; Hirata Y; Hagiwara T; Kawamura YI; Okamura T; Takanashi R; Nakano K; Tamura-Nakano M; Burkly LC; Dohi T
    World J Gastroenterol; 2017 Apr; 23(13):2294-2307. PubMed ID: 28428709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the ovotoxicity of 5-fluorouracil in mice.
    Lambouras M; Liew SH; Horvay K; Abud HE; Stringer JM; Hutt KJ
    J Assist Reprod Genet; 2018 Jun; 35(6):1053-1060. PubMed ID: 29589294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
    Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
    Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-Onset 5-Fluorouracil Toxicity in a Patient Negative for Dihydropyrimidine Dehydrogenase Mutations: The Clinical Course of Reversal with Uridine Triacetate.
    Vaudo CE; Gil B; Galuski K; Zarwan C; Nugent FW
    Pharmacotherapy; 2016 Nov; 36(11):e178-e182. PubMed ID: 27716991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of chemotherapy-related toxic side effects by infection with adeno-associated virus type 2.
    Eisold S; Dihlmann S; Linnebacher M; Ryschich E; Aulmann M; Schmidt J; Schlehofer JR; Ridder R; von Knebel Doeberitz M
    Int J Cancer; 2002 Aug; 100(5):606-14. PubMed ID: 12124812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies.
    Hidalgo M; Villalona-Calero MA; Eckhardt SG; Drengler RL; Rodriguez G; Hammond LA; Diab SG; Weiss G; Garner AM; Campbell E; Davidson K; Louie A; O'Neil JD; von Borstel R; Von Hoff DD; Rowinsky EK
    J Clin Oncol; 2000 Jan; 18(1):167-77. PubMed ID: 10623707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil.
    Baker SD; Diasio RB; O'Reilly S; Lucas VS; Khor SP; Sartorius SE; Donehower RC; Grochow LB; Spector T; Hohneker JA; Rowinsky EK
    J Clin Oncol; 2000 Feb; 18(4):915-26. PubMed ID: 10673535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.